Articles written by: Floyd Adamson

Reviewing Ladder Capital Corp (LADR)’s and Drive Shack Inc. (NYSE:DS)’s results

We are comparing Ladder Capital Corp (NYSE:LADR) and Drive Shack Inc. (NYSE:DS) on their profitability, analyst recommendations, institutional ownership, risk, dividends, earnings and valuation. They both are REIT – Diversified companies, competing one another. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ladder Capital […]

Heat Biologics Inc. (HTBX) and Neon Therapeutics Inc. (NASDAQ:NTGN) Comparing side by side

This is therefore a comparing of the institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation in Heat Biologics Inc. (NASDAQ:HTBX) and Neon Therapeutics Inc. (NASDAQ:NTGN). The two are both Biotechnology companies that compete with one another. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share […]

Comparison of Vaxart Inc. (VXRT) and NewLink Genetics Corporation (NASDAQ:NLNK)

Vaxart Inc. (NASDAQ:VXRT) and NewLink Genetics Corporation (NASDAQ:NLNK), are influenced by compare since they are both players in the Biotechnology. These factors are particularly influence the institutional ownership, profitability, risk, dividends, analyst recommendations, earnings and valuation of the two firms. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings […]

Reviewing Origin Agritech Limited (SEED)’s and Cresud Sociedad Anonima Comercial Inmobiliaria Financiera y Agropecuaria (NASDAQ:CRESY)’s results

We are contrasting Origin Agritech Limited (NASDAQ:SEED) and Cresud Sociedad Anonima Comercial Inmobiliaria Financiera y Agropecuaria (NASDAQ:CRESY) on their analyst recommendations, profitability, risk, institutional ownership, dividends, earnings and valuation. They both are Farm Products companies, competing one another. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share […]

Reviewing TRACON Pharmaceuticals Inc. (TCON)’s and Ampio Pharmaceuticals Inc. (NYSEAMERICAN:AMPE)’s results

Since TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Ampio Pharmaceuticals Inc. (NYSEAMERICAN:AMPE) are part of the Biotechnology industry, they are influenced by contrast. The influences particularly affect the analyst recommendations, institutional ownership, profitability, risk, dividends, earnings and valuation of both companies. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per […]

Apellis Pharmaceuticals Inc. (APLS) and Catabasis Pharmaceuticals Inc. (NASDAQ:CATB) Comparison side by side

Apellis Pharmaceuticals Inc. (NASDAQ:APLS) and Catabasis Pharmaceuticals Inc. (NASDAQ:CATB) compete against each other in the Biotechnology sector. We will compare them and contrast their institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Apellis Pharmaceuticals […]

Kazia Therapeutics Limited (KZIA)’s Financial Results Comparing With Aclaris Therapeutics Inc. (NASDAQ:ACRS)

Kazia Therapeutics Limited (NASDAQ:KZIA) and Aclaris Therapeutics Inc. (NASDAQ:ACRS) have been rivals in the Biotechnology for quite some time. Below is a review of each business including various aspects such as profitability, analyst recommendations, risk, institutional ownership, dividends, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income […]

Reviewing Molecular Templates Inc. (MTEM)’s and Assembly Biosciences Inc. (NASDAQ:ASMB)’s results

Molecular Templates Inc. (NASDAQ:MTEM) and Assembly Biosciences Inc. (NASDAQ:ASMB) have been rivals in the Biotechnology for quite some time. Below is a review of each business including various aspects such as dividends, analyst recommendations, profitability, risk, earnings and valuation, institutional ownership. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income […]

Reviewing Oragenics Inc. (OGEN)’s and Arcus Biosciences Inc. (NYSE:RCUS)’s results

Both Oragenics Inc. (NYSEAMERICAN:OGEN) and Arcus Biosciences Inc. (NYSE:RCUS) compete on a level playing field in the Biotechnology industry. We will evaluate their performance with regards to dividends, analyst recommendations, institutional ownership, profitability, risk, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings […]

Reviewing CohBar Inc. (CWBR)’s and BeiGene Ltd. (NASDAQ:BGNE)’s results

Both CohBar Inc. (NASDAQ:CWBR) and BeiGene Ltd. (NASDAQ:BGNE) are Biotechnology companies, competing one another. We will compare their dividends, analyst recommendations, profitability, institutional ownership, risk, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CohBar Inc. N/A 0.00 14.35M -0.35 0.00 BeiGene […]